Development of Novel Immune Cell Engagers Using Machine Intelligence

• Research type

  Research Study

• Full title

  Combining human and machine intelligence to accelerate the discovery of novel immune cell engagers.

• IRAS ID

  324096

• Contact name

  Daniel Foxler

• Contact email

  dan.foxler@labgeni.us

• Sponsor organisation

  LabGenius

• Clinicaltrials.gov Identifier

  N/A, N/A

• Duration of Study in the UK

  5 years, 0 months, 1 days

• Research summary

  This study aims to identify and quantify the expression of particular tumour markers within primary human tumours. This is to guide the design, validation and biological effect of novel drugs within LabGenius.

• REC name

  London - Camberwell St Giles Research Ethics Committee

• REC reference

  23/PR/0150

• Date of REC Opinion

  20 Feb 2023

• REC opinion

  Favourable Opinion